tirzepatide and levocarnitine compound Compounded Tirzepatide – HormoneNexus tirzepatide levocarnitine compound Compounded GLP-1/GIP

These products can be improperly compounded, incorrectly dosed, or counterfeit

Auto-renewal is the dominant 2026 complaint pattern, including Eden, Henry Meds, and MEDVi BBB filings

George and neighboring communities excess weight increases the risk of type 2 diabetes, high blood pressure, abnormal cholesterol, heart disease, stroke, fatty liver disease, sleep apnea, and chronic joint pain

Availability and Future Outlook Eli Lilly has announced plans to launch Zepbound under the brand name Mounjaro in India by 2025, pending regulatory approvals

The scale of the problem As of April 2025, the FDA had received over 520 adverse event reports related to compounded semaglutide